Condition

Malignant Respiratory Tract Neoplasm

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 2 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials2

Recruiting1

Common interventions12

Lead sponsors shown1

Clinical trials

2 shown

Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung CancerNCT03422302 · 2018-03-16

RECRUITING

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseNCT01552434 · 2012-10-16

TERMINATED

Common interventions

BevacizumabBIOLOGICAL1 Biphasic Positive Airway PressureDEVICE1 CetuximabBIOLOGICAL1 Computed TomographyPROCEDURE1 Continuous Positive Airway PressurePROCEDURE1 Deep Inspiration Breath HoldPROCEDURE1 Laboratory Biomarker AnalysisOTHER1 Pharmacological StudyOTHER1 Radiation Therapy Treatment Planning and SimulationRADIATION1 Stereotactic Body Radiation TherapyRADIATION1 TemsirolimusDRUG1 Valproic AcidDRUG1

Leading sponsors

M.D. Anderson Cancer Center2

Trial status mix

RECRUITING1

TERMINATED1

Phase mix

NA1

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.